SEC Form 4 · accession 0001567619-19-004920
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan W Ayers
Officer — Chairman, President & CEO · Director
Period of report
Feb 14, 2019
Accepted (ET)
Feb 19, 2019 · 6:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 14, 2019 | M | 1,774 | $0.00 | A | 1,033,096 | D | |
| Common Stock | Feb 14, 2019 | F | 824 | $206.94 | D | 1,032,272 | D | |
| Common Stock | holding | — | — | — | 138,000 | I | by Ayers Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right-to-buy)F4,F1 | $206.94 | Feb 14, 2019 | M | 78,170 | A | — | Feb 13, 2029 | Common Stock | 78,170 | 78,170 | D |
| Incentive Stock Option (right-to-buy)F4,F2 | $206.94 | Feb 14, 2019 | M | 483 | A | — | Feb 13, 2029 | Common Stock | 483 | 483 | D |
| Restricted Stock UnitF4,F3 | — | Feb 14, 2019 | M | 1,774 | D | — | — | Common Stock | 1,774 | 0 | D |
Explanation of responses
- F1Grant of option to buy shares of Issuer common stock that becomes exercisable in five annual installments beginning February 14, 2020.
- F2Grant of option to buy shares of Issuer common stock that becomes exercisable on the fifth anniversary of the date of grant.
- F3Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. The RSUs vested in five annual installments, beginning February 14, 2015. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015 (the "Stock Split").
- F4Not applicable.